Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Adjuvant Durvalumab for Esophageal Cancer

Phase 2

Conditions: Esophageal Cancer

Interventions: Drug: Durvalumab
Drug: Placebo

First Posted Date: 2015-08-11

Last Posted Date: 2019-12-09

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 86

Registration Number: NCT02520453

Locations: 🇰🇷
Samsung Medical Center, Seoul, MA, Korea, Republic of

The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease

Phase 2

Conditions: Coronary Syndrome

Interventions: Drug: Rosuvastatin
Drug: Olmesartan
Drug: Combination
Drug: Placebo of Rosuvastatin
Drug: Placebo of Rosuvastatin/Olmesartan(Combination)
Drug: Placebo of Olmesartan

First Posted Date: 2015-08-06

Last Posted Date: 2015-08-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 504

Registration Number: NCT02516826

Locations: 🇰🇷
Cardiac and Vascular Center; Samsung Medical Center, Seoul, Korea, Republic of

Thoracic Epidural for Postoperative Ileus

Not Applicable

Completed

Conditions: Ileus

Interventions: Drug: iv-PCA
Procedure: thoracic epidural analgesia

First Posted Date: 2015-07-08

Last Posted Date: 2015-07-08

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 28

Registration Number: NCT02491385

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

EAA/Therapy for Treating Children With ADHD

Not Applicable

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Behavioral: EAA/T
Drug: Methylphenidate
Drug: Atomoxetine

First Posted Date: 2015-06-26

Last Posted Date: 2015-06-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 46

Registration Number: NCT02482649

Locations: 🇰🇷
Yoo-Sook Joung, Seoul, Korea, Republic of

Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.

Phase 4

Completed

Conditions: Overactive Bladder

Interventions: Drug: mirabegron 50mg

First Posted Date: 2015-06-10

Last Posted Date: 2018-02-28

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 434

Registration Number: NCT02468375

Locations: 🇰🇷
Samsung Medical Center, Seoul,, Korea, Republic of

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

Phase 2

Conditions: Advanced, Refractory Cancer

Interventions: Drug: Imatinib

First Posted Date: 2015-06-03

Last Posted Date: 2022-06-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 14

Registration Number: NCT02461849

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: Ibuprofen
Drug: Hydromorphone

First Posted Date: 2015-06-03

Last Posted Date: 2015-06-03

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 90

Registration Number: NCT02461056

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation

Not Applicable

Completed

Conditions: Kidney Transplantation

Interventions: Procedure: Fluid loading

First Posted Date: 2015-06-02

Last Posted Date: 2015-06-02

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 42

Registration Number: NCT02459470

Locations: 🇰🇷
Samsung Seoul Hospital, Samsung Medical Center, Seoul, Korea, Republic of

Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis

Phase 4

Conditions: Stroke
Intracranial Atherosclerosis

First Posted Date: 2015-06-01

Last Posted Date: 2017-04-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 80

Registration Number: NCT02458755

Locations: 🇰🇷
Oh Young Bang, Seoul, Korea, Republic of

Pulse Pressure Variation Measured During Valsalva Maneuver to Predict Fluid Responsiveness Under Open-chest Condition

Completed

Conditions: Sternotomy
Thoracic Surgical Procedures
Cardiac Surgical Procedures

Interventions: Procedure: Valsalva maneuver
Other: Fluid loading

First Posted Date: 2015-05-29

Last Posted Date: 2015-09-14

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 55

Registration Number: NCT02457572

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy